Associate Professor Ken Howard is part of the Horizon 2020 Innovative Training Network (ITN), CARTHAGO, where the aim is to develop a treatment of intervertebral disc degeneration and osteoarthritis using non-viral gene therapy. (Photo: Maria Randima, AU 